RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
Menno de Jong appointed director of RIVM Centre for Infectious Disease Control Starting 1 May 2024, Professor Menno de Jong will take on the role of director of RIVM’s Centre for Infectious Disease Control (CIb) . He succeeds Jaap van Dissel, who is retiring in April 2024.
Start of rotavirus vaccinations This week saw the start of babies being vaccinated against the rotavirus. This vaccination is included in the Dutch National Immunisation Programme as of this year. All parents of babies born on or after 1 January 2024 will receive an invitation for this.
National Immunisation Programme: slightly more cases in 2022, but fewer than before the COVID-19 pandemic In 2022, a slightly higher number of people in the Netherlands contracted diseases covered by the National Immunisation Programme (NIP) compared to 2021. This increase is likely due to the easing of coronavirus measures, such as social distancing.
Combined exposure to high amounts of lead, cadmium, mercury and arsenic increases risk of kidney damage People can come into contact with chemicals that may affect their health through food and drinking water.
No changes to chromium (VI) adverse health effect list No changes will be made to the list of adverse health effects that may be caused by exposure to chromium (VI) in the workplace. According to RIVM, the latest scientific literature has resulted in no new insights.
RIVM and EFSA optimise new calculation model for mixture risk assessment Plant protection products (PPPs) are products used in agriculture to protect crops against, for example, fungi, insects and weeds.
Participation rates in cancer population screening programmes continue to decline The number of participants in the population screening programmes for breast cancer, cervical cancer and colorectal cancer continues to decline. This decline has been going on for years, reaching its lowest point in 2020.
Metabolic disorder ALD added to newborn blood spot screening Since 1 October, the metabolic disorder adrenoleukodystrophy (ALD) has been added to the Dutch newborn blood spot screening. From now on, the blood of newborn boys will also be tested for this disorder. ALD in boys can be treated if it is detected in time.
Improper use of methylphenidate Students sometimes use ADHD medicines that have not been prescribed to them in order to study more effectively. It is suspected that they obtain these medicines from other people, who do have a prescription. Sewage research conducted by RIVM supports this theory.